Knock-down of COX-2 expression or inhibition of COX-2 activity using a pharmacological inhibitor strikingly blocked TGF-β-induced tumorsphere formation, enrichment of CD24lowCD44high, ALDH+ breast cancer stem cells and breast cancer stem cell self-renewal [45]. The gene discussed is TGFB1; the disease is breast cancer.